e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Pathogenesis and risk of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence of lung cancer in smokers with and without COPD: Observational study
V. Moya, A. Boldova, E. Forcen, E. Minchole, J. M. Marín (Majadahonda ( Madrid), Zaragoza, Spain)
Source:
Annual Congress 2013 –Pathogenesis and risk of lung cancer
Session:
Pathogenesis and risk of lung cancer
Session type:
Thematic Poster Session
Number:
4509
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Moya, A. Boldova, E. Forcen, E. Minchole, J. M. Marín (Majadahonda ( Madrid), Zaragoza, Spain). Incidence of lung cancer in smokers with and without COPD: Observational study. Eur Respir J 2013; 42: Suppl. 57, 4509
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Is there a difference in the incidence of metastasis at diagnosis of lung cancer between smokers and non smokers?
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Lower rate of COPD exacerbations in patients with COPD and concurrent lung carcinoma – Data from the Bergmannsheil cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Description of smoking status in pulmonary patient in the discharge list
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Lung cancer in COPD patients on home oxygen-therapy
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Survival in patients with lung cancer, with and without self reported cardiovascular disease the HUNT study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Age related influence of COPD on postoperative pulmonary morbidity in lung cancer patients
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Psychological assessment in COPD and lung cancer patients in pulmonary rehabilitation
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Smoking patterns after lung cancer diagnosis: A pulmonology department experience
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Delay in diagnosis and management of lung cancer in developing countries
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept